[
  {
    "ts": "2025-10-22T15:14:31+00:00",
    "headline": "Can Charles River (CRL) Redefine Its Competitive Edge Through Science Partnerships and Non-Animal Testing?",
    "summary": "In recent days, Charles River Laboratories International announced several new collaborations, including with The Francis Crick Institute to accelerate Antibody-Drug Conjugate development and with X-Chem to expand access to its proprietary DNA-encoded library platform for hit identification in drug discovery. These collaborations, along with the launch of a global Scientific Advisory Board for alternative testing methodologies, highlight Charles River's commitment to innovation in drug...",
    "url": "https://finance.yahoo.com/news/charles-river-crl-redefine-competitive-151431202.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "e0be7752-333f-3f99-8c47-adda82310485",
      "content": {
        "id": "e0be7752-333f-3f99-8c47-adda82310485",
        "contentType": "STORY",
        "title": "Can Charles River (CRL) Redefine Its Competitive Edge Through Science Partnerships and Non-Animal Testing?",
        "description": "",
        "summary": "In recent days, Charles River Laboratories International announced several new collaborations, including with The Francis Crick Institute to accelerate Antibody-Drug Conjugate development and with X-Chem to expand access to its proprietary DNA-encoded library platform for hit identification in drug discovery. These collaborations, along with the launch of a global Scientific Advisory Board for alternative testing methodologies, highlight Charles River's commitment to innovation in drug...",
        "pubDate": "2025-10-22T15:14:31Z",
        "displayTime": "2025-10-22T15:14:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0Ih9Jyeb4E8RAOq22ZtFHA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r5jgPUxQrxmcesBmGBKgkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-crl-redefine-competitive-151431202.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-crl-redefine-competitive-151431202.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-22T12:00:00+00:00",
    "headline": "Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development",
    "summary": "WILMINGTON, Mass., October 22, 2025--Charles River Laboratories International, Inc. (NYSE: CRL) and The Francis Crick Institute (Crick) today announced a new collaboration around Antibody-Drug Conjugate (ADC) drug discovery and development, leveraging combined strengths to accelerate the development and delivery of next-generation targeted therapies.",
    "url": "https://finance.yahoo.com/news/charles-river-francis-crick-institute-120000336.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "dc5c84ce-5ded-3a62-86d7-adede3dc0e4d",
      "content": {
        "id": "dc5c84ce-5ded-3a62-86d7-adede3dc0e4d",
        "contentType": "STORY",
        "title": "Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development",
        "description": "",
        "summary": "WILMINGTON, Mass., October 22, 2025--Charles River Laboratories International, Inc. (NYSE: CRL) and The Francis Crick Institute (Crick) today announced a new collaboration around Antibody-Drug Conjugate (ADC) drug discovery and development, leveraging combined strengths to accelerate the development and delivery of next-generation targeted therapies.",
        "pubDate": "2025-10-22T12:00:00Z",
        "displayTime": "2025-10-22T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/7c9ccd14782cc6221b6d323dd11879af",
          "originalWidth": 1245,
          "originalHeight": 326,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hO1KQSlbwIuamIZE_ExPOw--~B/aD0zMjY7dz0xMjQ1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/7c9ccd14782cc6221b6d323dd11879af.cf.webp",
              "width": 1245,
              "height": 326,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/B5EdaZnbjfIHhXHQJSo2wQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/7c9ccd14782cc6221b6d323dd11879af.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-francis-crick-institute-120000336.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-francis-crick-institute-120000336.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]